Citations

Clear

2117 citation(s) found for "Mayo, Steven".

Society of Radiologists in Ultrasound response to ‘Proposed simplified protocol for initial assessment of endometriosis with transvaginal ultrasound’
Young, Scott W. , VanBuren, W., Kho, Rosanne M. , Groszmann, Yvette S. , Feldman, Myra , Khan, Zaraq , Young, S. L., Endometriosis, the Society of Radiologists in Ultrasound Consensus Panel on Routine Pelvic Ultrasound for, Young, Scott W , Jha, Priyanka , Rodgers, Shuchi K. , Burnett, Tatnai L. , Chamié, Luciana Pardini , Horrow, Mindy M. , Young, S. L., Young, Steven L. , Endometriosis, the Society of Radiologists in Ultrasound Consensus Panel on Routine Pelvic Ultrasound for

Mayo Clinic

Ultrasound in Obstetrics & Gynecology | November 27, 2024 | Volume: 65 | Issue: 2 | Pages: 243-245

10.1002/uog.29147 | PMID 39601344 Get It

Linked article: This Correspondence comments on Deslandes and Leonardi. Click here to view the article.
Treatment Options for Coronal Plane Fractures of the Lunate in Kienböck Disease
Dittman, Lauren E. , Munaretto, Nicholas , Lenartowicz, Karina A. , Shin, Alexander Y. , Moran, Steven L. , Kakar, Sanjeev , Tagliero, Lauren E , Lenartowicz, Karina, Shin, Alexander Y , Bishop, Allen, Kakar, Sanjeev , Munaretto, Nicholas , Bishop, Allen T.

Mayo Clinic

HAND | November 26, 2024 | Volume: 21 | Issue: 1 | Pages: 151-158

10.1177/15589447241298722 | PMID 39588834 Get It

Background: The treatment for Kienböck disease varies widely based on the status of the lunate. To date, there is no consensus regarding the optimal treatment for patients with coronal plane fractures of the lunate, or Lichtman Stage IIIC. Therefore, the purpose of this study was to assess whether coronal plane fractures of the lunate in Kienböck disease healed after surgical intervention, and to determine the outcomes after surgical fixation of the lunate compared with treatment with salvage procedures. Methods: A retrospective review of 36 patients with Lichtman IIIC Kienböck disease was conducted. Patients were classified into lunate reconstruction (vascularized bone graft [VBG] or non-VBG) or salvage procedures (proximal row carpectomy [PRC] or limited fusion). Preoperative and postoperative visual analog scale (VAS) pain, range of motion, grip strength, and Mayo Wrist Score (MWS) were analyzed. Radiographs and computed tomographic scans were reviewed for Lichtman stage, fracture location, union, modified carpal height ratio, Stahl index, and radioscaphoid angle. Results: Thirteen patients underwent lunate reconstruction, 13 underwent limited fusion, and 10 underwent PRC. The overall union rate was 45% after lunate reconstruction, with average time to union of 7 months. There were no differences in union rates between VBG and non-VBG. All 3 groups experienced improvement in their postoperative grip strength and MWS. There were no statistically significant differences in preoperative to postoperative changes in clinical outcome measures between the 3 cohorts; however, when we compared lunate reconstruction with all patients who underwent salvage procedures (limited carpal fusion and PRC), we noted the latter had improved functional outcomes ( P = .019). Four patients (31%) in the reconstruction cohort and 2 patients (8%) in the limited carpal fusion group required reoperation at latest follow-up. Conclusions: Union rate of coronal plane fractures in Kienböck disease remains variable. While the proportion of patients requiring reoperation was higher in the reconstruction group, all groups of patients experienced improvement in their clinical outcomes, without a significant difference between cohorts.
Lethal 5-Fluorouracil Toxicity in a Carrier of DPYD c.704G>A (p.R235Q)
Bembenek, Brianna M. , Joshy, Aneena, Offer, Steven M. , Offer, Steven M

Mayo Clinic

JCO Precision Oncology | November 22, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/po.24.00294 | PMID 39576955 Get It

Contraction of collagen gels seeded with tendon cells
Chen, M.-Y., Jeng, Lily, Sun, Y.-L., Zhao, C.-F., Zobitz, M. E., Moran, Steven L. , Amadio, Peter C. , An, K.-N.

Mayo Clinic

Biorheology: The Official Journal of the International Society of Biorheology | November 21, 2024 | Volume: 43 | Issue: 3-4 | Pages: 337-345

10.1177/0006355x2006043003004017 Get It

Knowledge of the adaptation of the soft tissue to mechanical factors and biomolecules would be essential to better understand the mechanism of tendon injury and to improve the outcome of tendon repair. The responses to these factors could be different for the distinct types of cells in the tendon: cells from the tendon sheath, fibroblasts from the epitenon surface, or fibroblasts from the internal endotenon. In this study, we examined the mechanical and histological characteristics of the rate of contraction of the collagen gel seeded with epitenon and endotenon fibroblasts. The rate of contraction and the mechanical property of the contracted construct depend on the gel concentration and also the treatment of TGF-β 1 .
Controlled low-density lipoprotein cholesterol attenuates cardiovascular risk mediated by elevated lipoprotein(a) after percutaneous coronary intervention
Mahmoud, Ahmed , Awad, Kamal , Ali, Nima Baba , Abdalla, Hesham, Badr, Amro , Elahi, Muhammad Ali , Pereyra, Milagros , Javadi, Niloofar , Bismee, Nadera N. , Lester, Steven J., Arsanjani, Reza, Pereyra, Milagros , Mahmoud, Ahmed K , Awad, Kamal , Farina, Juan M. , Abbas, Mohammed Tiseer , Scalia, Isabel G. , Alsidawi, Said , Arsanjani, Reza

Mayo Clinic

Coronary Artery Disease | November 14, 2024 | Volume: 36 | Issue: 3 | Pages: 183-189

10.1097/mca.0000000000001460 | PMID 39774184 Get It

Background Lipoprotein(a) [Lp(a)] is an independent, causal risk factor for cardiovascular disease. However, it is still unclear whether controlling low-density lipoprotein cholesterol (LDL-C) to optimal levels can attenuate cardiovascular risk mediated by elevated Lp(a), especially in the setting of secondary prevention. Methods Adult patients with a baseline Lp(a) measurement who underwent percutaneous coronary intervention (PCI) and reached their LDL-C target levels (<70 mg/dl) at Mayo Clinic sites between 2006 and 2017 were included. Primary outcomes included major adverse cardiovascular events (MACE) and all-cause mortality. Kaplan–Meier curves were created to compare the survival probabilities among patients with Lp(a) ≥ 50 mg/dl compared with Lp(a) < 50 mg/dl. Multivariable Cox regression analyses were performed to quantify the association of elevated Lp(a) with our relevant outcomes and to control for possible confounders. Results In total, 878 patients (median age: 68 years, and 74% males) who underwent PCI were included for analysis. Of them, 29.7% had elevated Lp(a) ≥ 50 mg/dl. Kaplan–Meier curves did not reveal any significant difference in survival probabilities for elevated Lp(a) for any outcome including MACE (P = 0.91), all-cause mortality (P = 0.26), or the separate MACE components. Similarly, the multivariable analysis showed no significant association for MACE (hazard ratio: 1.07, 95% confidence interval: 0.84–1.37) or all-cause mortality (hazard ratio: 0.98, 95% confidence interval: 0.74–1.30). Conclusion In patients who underwent PCI and have their LDL-C controlled below 70 mg/dl, no significant association was found between elevated Lp(a) ≥ 50 mg/dl and risk for MACE or all-cause mortality.
TMIC-67. EMERGING ROLE OF EXTRACELLULAR MATRIX STIFFNESS AS A HALLMARK OF GLIOBLASTOMA: INSIGHT TO MECHANICAL MEMORY FORMATION AND PROLONGED INVASION IN THE TUMOR PERIPHERY
Meade, Paola Suarez, Whitehead, Rachel, Teeter, Caroline, Aramburu, Manuela, Chaichana, Kaisorn L. , Rosenfeld, Steven S. , Kenchappa, Rajappa S., Hwang, Tae Hyun , Quiñones‐Hinojosa, Alfredo , Whitehead, Rachel, Clemenceau, Jean R. , Norton, Emily S. , Kulkarni, Tanmay , Hong, Changjin , Guerrero‐Cazares, Hugo , Schiapparelli, Paula , Κωνσταντόπουλος, Κωνσταντίνος

Mayo Clinic

Neuro-Oncology | November 11, 2024 | Volume: 26 | Issue: Supplement_8 | Pages: viii313-viii313

10.1093/neuonc/noae165.1245 Get It

Abstract The extracellular matrix (ECM) plays a critical role in cancer progression, with its biophysical properties influencing cancer behavior. ECM stiffness can induce long-lasting adaptations in cancer cells, promoting sustained invasion through a process known as “mechanical memory” (MM). Glioblastoma (GBM) exhibits spatial heterogeneity in stiffness, with stiffer ECM found at the tumor periphery where invasive cells reside and promote recurrence. We hypothesize that increased stiffness at the tumor periphery primes GBM cells for sustained invasion through MM. METHODS Cell lines were established from image-guided human GBM samples from tumor margin and core (n=10 patients, 20 cell lines). Cells from random locations were conditioned in physiologically relevant extracellular matrices for two weeks. Human organotypic assay (n=3), Migration Assays, Atomic Force Microscopy (AFM), Immunocytochemistry, Western Blot, and RNA-sequencing (n=6) were performed. RESULTS GBM cells at higher stiff surfaces displayed increased migration (p&lt;0.01). Magnetic Resonance Elastography (n=9) confirmed GBM heterogeneity, with softer cores (0.2-0.5kPa) transitioning to stiffer margins (&gt;2kPa). Organotypic scaffolds mimicking the tumor margin promoted enhanced migration of GFP-labeled GBM cells. Margin cells and cells conditioned on stiffer matrices demonstrated higher migratory potential compared to their core and soft-conditioned counterparts (p&lt;0.05). These trends persist over time and across multiple passages. ECM stiffness exposure causes nanomechanical, cytoskeletal, and transcriptional adaptations. AFM shows that cells from the margin (n=6) are softer (p&lt;0.01) and more deformable (p&lt;0.01). RNAseq identified upregulation of MM-specific genes in GBM margin cells. The mechanosensitive transcription factor YAP1 emerged as a key driver of MM. Notably, YAP1 is targetable by the FDA-approved drug Verteporfin. YAP1 expression was elevated in margin and stiff-conditioned cells (p&lt;0.05). Stiff-conditioned cells and margin cells displayed increased sensitivity to Verteporfin treatment (p&lt;0.05), with treatment significantly reducing margin migration compared to the core (p&lt;0.001). CONCLUSION Stiffer GBM margins promote the formation of aggressive phenotypes through MM. Targeting YAP1 with Verteporfin, a readily available drug, presents a promising strategy to halt GBM invasion and improve patient outcomes.
CSIG-03. MT-125 INHIBITS NON-MUSCLE MYOSIN IIA AND IIB, SYNERGIZES WITH ONCOGENIC KINASE INHIBITORS, AND PROLONGS SURVIVAL IN GLIOBLASTOMA
Rosenfeld, Steven S. , Kenchappa, Rajappa S., Dovas, Athanassios, Haddock, Ashley , Canoll, Peter, Rumbaugh, Gavin , Griffin, Patrick , Miller, Courtney , Radnai, László , Zarco, Natanael , Griffin, Patrick, Kamenecka, Theodore M.

Mayo Clinic

Neuro-Oncology | November 11, 2024 | Volume: 26 | Issue: Supplement_8 | Pages: viii63-viii64

10.1093/neuonc/noae165.0252 Get It

Abstract We have shown that members of the non-muscle myosin II (NMII) family of molecular motors are non-redundant drivers of both invasion and proliferation in glioblastoma (GBM), consistent with the canonical roles NMII isoforms play in cell motility and cytokinesis. However, we have also found that NMII also has a non-canonical role by regulating oncogenic signaling pathways relevant to GBM pathogenesis. This unexpected finding has led us to identify and characterize MT-125, a highly specific small molecule inhibitor of the two predominant NMII isoforms in GBM (NMIIA and NMIIB), and we have studied its effects in pre-clinical GBM models. MT-125 has high brain penetrance and retention; an excellent safety profile in rodents and canines with no changes in metabolic or hematologic indices after prolonged administration; is well-tolerated with daily dosing for at least 85 consecutive days; blocks GBM invasion and cytokinesis, consistent with the canonical roles of NMII; and prolongs median survival by 35% as a single agent in murine GBM models. MT-125 increases signaling along both the PDGFR- and MAPK-driven pathways through a mechanism that involves the upregulation of reactive oxygen species, leading to oncogene addiction to these pathways. As a consequence, MT-125 is synthetically lethal when combined with FDA-approved, CNS-permeant inhibitors of PDGFR and mTOR in vitro. Combining MT-125 with sunitinib, a PDGFR inhibitor, or paxalisib, a combined PI3 Kinase/mTOR inhibitor, in vivo doubles median survival in a highly aggressive murine orthotopic GBM model. Furthermore, combining MT-125 with sunitinib produces tumor free remissions of &gt;100 days--2.5-fold greater than median survival of either drug alone—in approximately 40% of mice. Our results provide a powerful rationale for developing NMII targeting strategies to treat cancer and demonstrate that MT-125 has strong clinical potential for the treatment of GBM.
Spinal cord evaluation in multiple sclerosis: clinical and radiological associations, present and future
Keegan, B. Mark , Absinta, Martina , Henry, Roland G. , Klawiter, Eric C. , Kolind, Shannon , Krieger, Stephen, Laule, Cornelia , Lincoln, John A. , Papinutto, Nico , Smith, Seth A., Flanagan, E P , Henry, Roland G , Klawiter, Eric C , Laule, Cornelia , Messina, Steven, Traboulsee, Anthony , Keegan, B Mark , Kollind, Shannon H , Cohen-Adad, Julien , Flanagan, Eoin P. , Messina, Steven A. , Oh, Jiwon

Mayo Clinic

Brain Communications | November 6, 2024 | Volume: 6 | Issue: 6 | Pages: No page available

10.1093/braincomms/fcae395 | PMID 39611182 Get It

Abstract Spinal cord disease is important in most people with multiple sclerosis, but assessment remains less emphasized in patient care, basic and clinical research and therapeutic trials. The North American Imaging in Multiple Sclerosis Spinal Cord Interest Group was formed to determine and present the contemporary landscape of multiple sclerosis spinal cord evaluation, further existing and advanced spinal cord imaging techniques, and foster collaborative work. Important themes arose: (i) multiple sclerosis spinal cord lesions (differential diagnosis, association with clinical course); (ii) spinal cord radiological–pathological associations; (iii) ‘critical’ spinal cord lesions; (iv) multiple sclerosis topographical model; (v) spinal cord atrophy; and (vi) automated and special imaging techniques. Distinguishing multiple sclerosis from other myelopathic aetiology is increasingly refined by imaging and serological studies. Post-mortem spinal cord findings and MRI pathological correlative studies demonstrate MRI’s high sensitivity in detecting microstructural demyelination and axonal loss. Spinal leptomeninges include immune inflammatory infiltrates, some in B-cell lymphoid-like structures. ‘Critical’ demyelinating lesions along spinal cord corticospinal tracts are anatomically consistent with and may be disproportionately associated with motor progression. Multiple sclerosis topographical model implicates the spinal cord as an area where threshold impairment associates with multiple sclerosis disability. Progressive spinal cord atrophy and ‘silent’ multiple sclerosis progression may be emerging as an important multiple sclerosis prognostic biomarker. Manual atrophy assessment is complicated by rater bias, while automation (e.g. Spinal Cord Toolbox), and artificial intelligence may reduce this. Collaborative research by the North American Imaging in Multiple Sclerosis and similar groups with experts combining distinct strengths is key to advancing assessment and treatment of people with multiple sclerosis spinal cord disease.
Optimizing End Points for Phase III Cancer Trials
Schild, Steven E. , Schild, Steven

Mayo Clinic

JCO Clinical Cancer Informatics | November 6, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/cci-24-00210 | PMID 39504514 Get It

Teflon Granuloma With Active Inflammation: A Cause of Recurrent Trigeminal Neuralgia After Microvascular Decompression
Herber, Steven C., Zimmerman, Richard S. , Yang, Ming , Martinez, Felipe , Herber, Steven, Chen, Alicia

Mayo Clinic

Clinical Nuclear Medicine | October 31, 2024 | Volume: 49 | Issue: 12 | Pages: 1105-1108

10.1097/rlu.0000000000005444 | PMID 39479994 Get It

Abstract Trigeminal neuralgia (TN) is characterized by excruciating facial pain usually caused by neurovascular compression of the trigeminal nerve roots. TN can be treated medically or invasively. Microvascular decompression is the procedure of choice and usually results in complete symptom relief. During surgical decompression, Teflon can be placed between the offending vessel and the nerve root entry zone. In some cases, chronic Teflon-related inflammation can cause recurrent TN, which might lead to additional surgical intervention. We present imaging and histopathological correlation of a patient presenting with intractable recurrent TN approximately 2 years after microvascular decompression with Teflon implant.